Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.

Abstract

The Thomsen-Friedenreich (TF) antigen is expressed in a majority of human tumors due to aberrant glycosylation in cancer cells. There is strong evidence that humoral immune response to TF represents an effective mechanism for the elimination of cancer cells that express TF-positive glycoconjugates. The presence of naturally occurring antibodies to tumor-associated TF and cancer-specific changes in their levels, isotype distribution and interrelation, avidity, and glycosylation profile make these Abs a convenient and ubiquitous marker for cancer diagnostics and prognostics. In this review, we attempt to summarize the latest data on the potential of TF-specific Abs for cancer diagnostics and prognostics.

• Authors: Oleg Kurtenkov
• Journal: BioMed research international (Biomed Res Int) Vol. 2020 Pg. 9747040 ( 2020) ISSN: 2314-6141 [Electronic] United States
• PMID: 32280709 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2020 Oleg Kurtenkov.

Chemical References

• Antibodies
• Antigens, Tumor-Associated, Carbohydrate
• Glycoconjugates
• Thomsen-Friedenreich antigen

Topics

• Antibodies (immunology)
• Antigens, Tumor-Associated, Carbohydrate (immunology, metabolism)
• Glycoconjugates
• Glycosylation
• Health
• Humans
• Neoplasms (immunology, metabolism)
• Prognosis